The inhibition by flavonoids of 2-amino-3-methylimidazo[4,5-f]quinoline metabolic activation to a mutagen: a structure–activity relationship study
- 1 September 1997
- journal article
- Published by Elsevier in Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis
- Vol. 379 (1) , 21-32
- https://doi.org/10.1016/s0027-5107(97)00085-7
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Cytosolic Activation of Aromatic and Heterocyclic Amines. Inhibition by Dicoumarol and Enhancement in Viral Hepatitis BEnvironmental Health Perspectives, 1994
- The structure—activity relationships of flavonoids as inhibitors of cytochrome P-450 enzymes in rat liver microsomes and the mutagenicity of 2-amino-3-methyl-imidazo[4,5-f]quinolineMutagenesis, 1994
- Antimutagenic effects of flavoniods, chalcones and structurally related compounds on the activity of 2-amino-3-methylinidazo[4,5-ƒ]quinoline (IQ) and other heterocyclic amine mutagens from cooked foodMutation Research - Fundamental and Molecular Mechanisms of Mutagenesis, 1993
- Modulation of the mutagenic response in prokaryotesMutation Research - Fundamental and Molecular Mechanisms of Mutagenesis, 1992
- Cytosolic activation of 2-aminoanthracene: Implications in its use as diagnostic mutagen in the Ames testMutation Research - Fundamental and Molecular Mechanisms of Mutagenesis, 1992
- Alternatives to Aroclor 1254-induced S9 in in vitro genotoxicity assaysMutagenesis, 1992
- Fruit, vegetables, and cancer prevention: A review of the epidemiological evidenceNutrition and Cancer, 1992
- Dietary inhibitors of mutagenesis and carcinogenesisMutation Research - Fundamental and Molecular Mechanisms of Mutagenesis, 1988
- Metabolic activation of 2-amino-3-methylimidazo(4, 5-f)quinoline by hepatic preparations — contribution of the cytosolic fraction and its significance to strain differencesMutagenesis, 1986
- Enhancement of S9 activation by S105 cytosolic fractionCarcinogenesis: Integrative Cancer Research, 1981